References
- Yoshida Y. Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology. Ann Hematol. 2008;87(11):877–879. doi: https://doi.org/10.1007/s00277-008-0553-1
- Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol. 2008;142(4):505–514. doi: https://doi.org/10.1111/j.1365-2141.2008.07216.x
- Hirokawa M, Sawada K, Fujishima N, et al. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group. Br J Haematol. 2015;169(6):879–886. doi: https://doi.org/10.1111/bjh.13376
- Dessypris EN. Aplastic anemia and other bone marrow failure syndromes: pure red cell aplasia. New York: Springer Press; 1990.
- Frickhofen N, Chen ZJ, Yong NS, et al. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol. 1994;87(4):818–824. doi: https://doi.org/10.1111/j.1365-2141.1994.tb06743.x
- Crabol Y, Terrier B, Rozenberg F, et al. Intravenous immunoglobulin therapy for pure red cell aplasia related to human parvovirus b19 infection: a retrospective study of 10 patients and review of the literature. Clin Infect Dis. 2013;56(7):968–977. doi: https://doi.org/10.1093/cid/cis1046
- Krantz SB, Kao V. Studies on red cellaplasia. I. Demonstration of a plasma inhibitor to heme synthesis and an antibody to erythroblast nuclei. Proc Natl Acad Sci USA. 1967;58(2):493–500. doi: https://doi.org/10.1073/pnas.58.2.493
- Casadevall N, Nataf J, Viron B, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346(7):469–475. doi: https://doi.org/10.1056/NEJMoa011931
- Masuda M, Arai Y, Okamura T, et al. Pure red cell aplasia with thymoma: evidence of T-cell clonal disorder. Am J Hematol. 1997;54(4):324–328. doi: https://doi.org/10.1002/(SICI)1096-8652(199704)54:4<324::AID-AJH12>3.0.CO;2-B
- Fujisao S, Tsuda H. Th1/Th2 balance alteration in the clinical course of a patient with pure red cell aplasia and thymoma. Br J Haematol. 1998;103(2):308–310. doi: https://doi.org/10.1046/j.1365-2141.1998.01011.x
- Higuchi M, Osaki K, Yamano Y. Relapse of autoimmune hemolytic anemia in Evans syndrome after thymectomy for pure red cell aplasia. Rinsho Ketsueki. 2007;48(6):501–504.
- Hara T, Mizuno Y, Nagata M, et al. Human gamma delta T-cell receptor-positive cell-mediated inhibition of erythropoiesis in vitro in a patient with type autoimmune polyglandular syndrome and pure red blood cell aplasia. Blood. 1990;75(4):941–950.
- Handgretinger R, Geiselhart A, Moris A, et al. Pure Red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. N Eng J Med. 1999;340(4):278–284. doi: https://doi.org/10.1056/NEJM199901283400405
- Sivakumaran M, Bhavnani M, Stewart A, et al. Is pure red cell aplasia (PRCA) a clonal disorder? Clin Lab Haematol. 1993;15(1):1–5. doi: https://doi.org/10.1111/j.1365-2257.1993.tb00115.x
- Masuda M, Saitoh H, Mizoguchi H. Clonality of acquired primary pure red cell aplasia. Am J Hematol. 1999;62(3):193–195. doi: https://doi.org/10.1002/(SICI)1096-8652(199911)62:3<193::AID-AJH10>3.0.CO;2-D
- Means RJ. Pure red cell aplasia. Blood. 2016;128(21):2504–2509. doi: https://doi.org/10.1182/blood-2016-05-717140
- Sawada K, Hirokawa M, Fujishima N. Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin N Am. 2009;23(2):249–259. doi: https://doi.org/10.1016/j.hoc.2009.01.009
- Kim AR, Ulirsch JC, Wilmes S, et al. Functional selectivity in cytokine signaling revealed through a pathogenic EPO mutation. Cell. 2017;168(6):1053–1064. doi: https://doi.org/10.1016/j.cell.2017.02.026
- Shao Y, Wang H, Liu C, et al. Transforming growth factor 15 increased in severe aplastic anemia patients. Hematology. 2017;22(9):548–553. doi: https://doi.org/10.1080/10245332.2017.1311462
- Owusu-Ansah E, Banerjee U. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature. 2009;461:537–541. doi: https://doi.org/10.1038/nature08313
- Kops GJ, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316–321. doi: https://doi.org/10.1038/nature01036
- Kojima M, Machida S, Sato A, et al. Deferasirox treatment improved hematopoiesis and led to complete remission in a patient with pure red cell aplasia. Int J Hematol. 2013;98(6):719–722. doi: https://doi.org/10.1007/s12185-013-1455-0
- Sawada K, Hirokawa M, Fujishima N, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 2007;92(8):1021–1028. doi: https://doi.org/10.3324/haematol.11192
- Hirokawa M, Sawada K, Fujishima N, et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica. 2008;93(1):27–33. doi: https://doi.org/10.3324/haematol.11655
- Fujishima N, Sawada K, Hirokawa M, et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a nationwide cohort study in Japan for the PRCA collaborative study group. Haematologica. 2008;93(10):1555–1559. doi: https://doi.org/10.3324/haematol.12871